Sustained-Release Fampridine for Symptomatic Treatment of Multiple Sclerosis

200846 citationsReview

Authors

Anne R Korenke · Community Medical Center

Michael P. Rivey · Community Medical Center

Douglas Allington · Community Medical Center

Abstract

Positive results from 2 Phase 3 clinical trials have put fampridine-SR on the path toward approval as a medication for improving walking speed and lower extremity strength in patients with MS.

Topics & Keywords

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Pharmacotherapy

Volume 42, Issue 10, pp. 1458-1465

DOI: 10.1345/aph.1l028

Field-Weighted Citation Impact: 3.09